| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528221 | Clinical Therapeutics | 2018 | 12 Pages |
Abstract
Therapeutic classification and agent type, in addition to capital type and United States and European Union evaluation status suggested by a previous study, were associated with implementing MRCT-JP. It is important to determine the best way to utilize MRCT-JP to maximize the value of products. Our findings were based on successful cases and may therefore be helpful for designing clinical development plans. Appropriate use of MRCT-JP will improve productivity in the pharmaceutical industry.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Mitsuhiro MS, Naoki PhD, Katsura PhD,